𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of calcium and thrombin on growth factor release from platelet concentrates: Kinetics and regulation of endothelial cell proliferation

✍ Scribed by I Martineau; E Lacoste; G Gagnon


Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
568 KB
Volume
25
Category
Article
ISSN
0142-9612

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Growth factor-induced proliferation of h
✍ Christer Betsholtz; Bengt Westermark 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 872 KB

## Abstract Human neonatal skin fibroblasts plated sparsely in MCDB 105 traversed a complete cell cycle in the absense of serum or serum‐derived proteins. Addition of pure PDGF did not significantly increase entrance into S phase as revealed by ^3^H‐thymidine labeling index or clonal growth on pall

Different inhibitory effect of imatinib
✍ Akiko Ohashi; Kazuo Kinoshita; Koji Isozaki; Toshirou Nishida; Yasuhisa Shinomur 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 195 KB 👁 1 views

## Abstract Most gastrointestinal stromal tumors (GISTs) have gain‐of‐function mutations of the c‐__kit__ gene. Previously, we found 2 types of gain‐of‐function mutation of the __PDGFRA__ gene, Val^561^ to Asp and Asp^842^ to Val, in about half of GISTs without c‐__kit__ gene mutations. Although th

Inhibitory effects of a luteinizing horm
✍ Ying-tang Huang; Jiuan-jiuan Hwang; Lung-ta Lee; Charles Liebow; Ping-ping H. Le 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 556 KB

## Abstract The purpose of this study was to investigate the effects of a potent LHRH agonist, [D‐Trp^6^]LHRH on the basal and EGF‐induced cell proliferation and the metastasis‐associated properties in A431 human epidermoid carcinoma. [D‐Trp^6^]LHRH time‐dependently inhibited the basal and EGF‐stim

Inhibition of proliferation in human MNN
✍ Ryszard Braczkowski; Andrew V. Schally; Artur Plonowski; Jozsef L. Varga; Kate G 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 2 views

## Abstract ## BACKGROUND Antagonists of growth hormone‐releasing hormone (GH‐RH) can inhibit the proliferation of various tumors either indirectly through the suppression of the pituitary growth hormone/hepatic insulin‐like growth factor I (__IGF‐I__) axis and the lowering of serum __IGF‐I__ conc